Anti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial
Titel:
Anti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial
Auteur:
Papp, Kim A. Reid, Cathy Foley, Peter Sinclair, Rod Salinger, David H. Williams, Gary Dong, Hua Krueger, James G. Russell, Chris B. Martin, David A.